Please assess the completion status of the following clinical trial:

Trial Title: Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets criteria for current marijuana addiction and reports marijuana as primary drug of abuse~* Currently meets criteria for major depression or dysthymic disorder and receive a score of greater than or equal to 12 on the Hamilton Depression Inventory~* Clinically depressed for at least 3 months during a period of active marijuana use~* Women of child-bearing age will be included provided that they are not pregnant, based on the results of a blood pregnancy done at the time of screening and agree to use a method of contraception with proven efficacy and not to become pregnant during the study. To confirm this, blood pregnancy tests will be repeated monthly. Women will be provided a full explanation of the potential dangers of pregnancy while on the study. If a woman becomes pregnant, the study medication will be discontinued.~Exclusion Criteria:~* Meets criteria for past manic or psychotic disorder, unless substance-related~* History of a seizure disorder~* Individuals with chronic organic mental syndrome~* Any significant risk for suicide based on current assessment and history of attempts~* History of allergic reaction to either Venlafaxine or Ven-XR~* Unstable physical disorders that might make participation hazardous, such as uncontrolled hypertension and tachycardia (SBP\>150, DBP \>90, or a sitting quietly HR\>100), acute hepatitis (patients with chronic mildly elevated transaminase levels (\<2x upper limit of normal are acceptable) or unstable diabetes~* History of failure to respond to a previous adequate trial of Venlafaxine of at least 300 mg. for at least a 6-week period~* Physical dependence on any other drugs (excluding nicotine) that would require medical detoxification~* Currently being prescribed psychotropic medication by another physician (in the last 3 weeks), except for acute treatment of insomnia.~* Pregnant or breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Venlafaxine (Type: ACTIVE_COMPARATOR): Venlafaxine
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).